🔎 Trials Near Me

Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials recruiting in the U.S.

23 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT01087333

Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05289687

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

RecruitingPhase 1
Up to age 39 · All sexes · Updated Sep 11, 2026 · NCT04972942

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

RecruitingPhase 1
Up to age 75 · All sexes · Updated Aug 11, 2026 · NCT03081910

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

RecruitingPhase 1
Ages 0 to 29 · All sexes · Updated Jul 7, 2026 · NCT06934382

Registry of Older Patients With Cancer

RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825

A Registry for People With T-cell Lymphoma

RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04318678

Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

RecruitingPhase 1
Up to age 75 · All sexes · Updated May 18, 2026 · NCT07220993

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT07356245

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT05996185

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT06698003

Two Step Haplo With Radiation Conditioning

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 30, 2025 · NCT05031897

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 27, 2025 · NCT01137643

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 15, 2025 · NCT06462365

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.